Lir Life Sciences Corp. (CVE:SKNY) | WebDisclosure

Basculer en Français

10524	Companies
221978	Keywords
151170	Articles
117435	Press releases

Headlines Articles Press releases Lir Life Sciences Corp.

Home
Companies
Lir Life Sciences Corp.

BRIEF

published on 05/23/2026 at 01:05, 14 days 1 hour ago

LIR Life Sciences lance la phase 1 du développement d'un dispositif d'administration transdermique

Administration Transdermique LIR Sciences De La Vie Laboratoires Neuland Phase 1 Du Développement Synthèse De Macromolécules
BRIEF

published on 05/23/2026 at 01:05, 14 days 1 hour ago

LIR Life Sciences Initiates Phase 1 Transdermal Delivery Development

Transdermal Delivery LIR Life Sciences Neuland Laboratories Phase 1 Development Macromolecule Synthesis
PRESS RELEASE

published on 05/23/2026 at 01:00, 14 days 1 hour ago

LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
Neuland Laboratories Limited orders raw materials for Phase 1 of macromolecule-enabled transdermal delivery development with LIR Life Sciences Corp. to advance needle-free, skin-applied peptide therapies

Phase 1 Lir Life Sciences Corp. Neuland Laboratories Limited Macromolecule-enabled Transdermal Delivery Needle-free Peptide Therapies
BRIEF

published on 04/29/2026 at 00:05, 1 month 7 days ago

LIR Life Sciences lance une étude ex vivo sur l'efficacité de la protamine par voie transdermique.

Accouchement Sans Aiguille Amélioration De La Protamine Transport Transdermique Molécules Thérapeutiques Étude Ex Vivo
BRIEF

published on 04/29/2026 at 00:05, 1 month 7 days ago

LIR Life Sciences Initiates Ex Vivo Study on Protamine's Efficacy in Transdermal Delivery

Ex Vivo Study Needle-free Delivery Protamine Enhancement Transdermal Transport Therapeutic Molecules
PRESS RELEASE

published on 04/29/2026 at 00:00, 1 month 7 days ago

LIR Life Sciences Launches Ex Vivo Animal Study to Evaluate Protamine Enhanced Transdermal Transport of Larger Format Therapeutic Molecules
LIR Life Sciences Corp. announces the launch of a controlled ex vivo porcine skin study to evaluate protamine's impact on transdermal movement of macromolecular therapeutics. The study aims to advance needle-free delivery options for larger molecules

Transdermal Delivery Lir Life Sciences Corp. Needle-free Delivery Protamine Macromolecular Therapeutics
BRIEF

published on 04/21/2026 at 00:05, 1 month 15 days ago

LIR Life Sciences Corp. Partners with Resilience BioSciences Inc.

Drug Development Preclinical Research Technology Collaboration Novel Therapies Academic Environment
BRIEF

published on 04/21/2026 at 00:05, 1 month 15 days ago

LIR Life Sciences Corp. s'associe à Resilience BioSciences Inc.

Recherche Préclinique Collaboration Technologique Développement De Médicaments Nouvelles Thérapies Environnement Académique
PRESS RELEASE

published on 04/21/2026 at 00:00, 1 month 15 days ago

LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.
LIR Life Sciences Corp. announces a Technology Development Collaboration Agreement with Resilience BioSciences Inc. to enhance preclinical research activities in drug discovery and development

Drug Discovery Life Sciences Collaboration Agreement Preclinical Research Resilience BioSciences
BRIEF

published on 02/06/2026 at 00:05, 4 months ago

LIR Life Sciences Initiates Phase 2 Peptide Design with Neuland Laboratories

Transdermal Delivery LIR Life Sciences Neuland Laboratories Peptide Design Structure-Activity Relationships

1 2 ... 4

Accesswire

Published on 06/06/2026 at 00:00, 2 hours 37 minutes ago

Onco-Innovations Signs LOI with Nanosoft Polymers to Advance Polymer and Drug Delivery Development for the ONC010 Program
Published on 06/05/2026 at 17:00, 9 hours 37 minutes ago

Silver Spruce Resources Inc. Provides an Update on the Jackie Project Acquisition
Published on 06/05/2026 at 15:00, 11 hours 37 minutes ago

Norsemont Drills 20 Meters of 1.20 G/T Gold Equivalent at Bottom of Hole
Published on 06/05/2026 at 13:30, 13 hours 7 minutes ago

CANEX Announces Gold Basin Resources Shareholders Approve Merger Arrangement With CANEX With 75.82% Support
Published on 06/05/2026 at 13:00, 13 hours 37 minutes ago

Ur-Energy Reports Results of Annual General and Special Meeting of Shareholders

View all ACCESSWIRE

EQS Group

Published on 06/06/2026 at 00:20, 2 hours 17 minutes ago

Guild Wars 3, Modern Evolution of the MMORPG, Announced at Summer Game Fest for PC and PlayStation 5
Published on 06/05/2026 at 23:05, 3 hours 32 minutes ago

Quantinuum Announces Closing of Upsized Initial Public Offering
Published on 06/05/2026 at 19:06, 7 hours 31 minutes ago

EQS-Adhoc: Brockhaus Technologies AG: The Company's Management Board intends to return approx. €180 million of the proceeds from the sale of the Bikeleasing Group to shareholders
Published on 06/05/2026 at 18:48, 7 hours 49 minutes ago

Digital transformation journey takes centre stage at ANGOTIC 2026
Published on 06/05/2026 at 18:32, 8 hours 5 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 06/05/2026 at 19:00, 7 hours 37 minutes ago

ALTAREA - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 06/05/2026 at 19:00, 7 hours 37 minutes ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 06/05/2026 at 19:00, 7 hours 37 minutes ago

ALTAREIT - Descriptif du programme de rachat d'actions autorisé par l'assemblée générale mixte du 4 juin 2026 et mis en œuvre par la Gérance
Published on 06/05/2026 at 19:00, 7 hours 37 minutes ago

ALTAREA : Descriptif du programme de rachat d'actions autorisé par l'assemblée générale mixte du 4 juin 2026 et mis en œuvre par la Gérance
Published on 06/05/2026 at 19:00, 7 hours 37 minutes ago

ALTAREIT - DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES MAI 2026

View all LES ECHOS COMFI WIRE